GOLIMUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) OR ANKYLOSING SPONDYLITIS (AS) - SUBANALYSIS FROM THE NON-INTERVENTIONAL EVALUATION GO-NICE

被引：0

作者：

Krueger, K. ^{[1
]}

Burmester, G. R. ^{[2
]}

Wassenberg, S. ^{[3
]}

Bohl-Buehler, M. ^{[4
]}

Thomas, M. H. ^{[5
]}

机构：

[1] Rheumatol Praxiszentrum, Munich, Germany

[2] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany

[3] Rheumazentrum Ratingen, Ratingen, Germany

[4] Rheumahaus Potsdam GbR, Potsdam, Germany

[5] MSD Sharp & Dohme GmbH, Med Affairs, Haar, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷

关键词：

D O I：

10.1136/annrheumdis-2017-eular.5154

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0203

引用

页码：558 / 559

页数：2

共 50 条

[1] Golimumab in Biologic-NaiVe Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis from a Non-Interventional Evaluation in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Bohl-Buehler, Martin
Thomas, Matthias H.
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[2] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Bohl-Buehler, Martin
Thomas, Matthias H.
[J]. RHEUMATOLOGY INTERNATIONAL, 2019, 39 (01) : 131 - 140
[3] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
Klaus Krüger
Gerd R. Burmester
Siegfried Wassenberg
Martin Bohl-Bühler
Matthias H. Thomas
[J]. Rheumatology International, 2019, 39 : 131 - 140
[4] Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Bohl-Buehler, Martin
Thomas, Matthias H.
[J]. BMJ OPEN, 2018, 8 (06):
[5] Clinical Outcomes of Golimumab As Second Line TNF Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis of a Non-Interventional Study in Germany
Krueger, Klaus
Burmester, Gerd R.
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias H.
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[6] SOCIOECONOMIC ANALYSIS OF GOLIMUMAB TREATMENT IN PATIENTS WITH RA, PSA, AND AS - NON-INTERVENTIONAL STUDY GO-NICE
Krueger, Klaus
Burmester, Gerd Ruediger
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 622 - 623
[7] Golimumab as First, Second or at Least Third Biologic Agent in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Post Hoc Analysis of a Non-Interventional Study in Germany
Krueger, Klaus
Burmester, Gerd
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[8] GOLIMUMAB AS FIRST, SECOND OR AT LEAST THIRD BIOLOGIC AGENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) OR ANKYLOSING SPONDYLITIS (AS) - POST HOC ANALYSIS OF A NON-INTERVENTIONAL STUDY IN GERMANY
Krueger, Klaus
Burmester, Gerd Ruediger
Wassenberg, Siegfried
Thiele, Astrid
Thomas, Matthias
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1156 - 1157
[9] Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): Interim Results from a Non-Interventional Trial in Germany
Krueger, Klaus
Remstedt, Sven
Thiele, Astrid
Klaudius, Ines
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[10] A NON-INTERVENTIONAL CLINICAL STUDY EVALUATING THE USE OF GOLIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA), AND ANKYLOSING SPONDYLITIS (AS) IN A REAL-LIFE SETTING IN GERMANY
Krueger, K.
Burmester, G. R.
Wassenberg, S.
Bohl-Buehler, M.
Thomas, M. H.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 232 - 232

← 1 2 3 4 5 →